Pathstone Holdings’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Sell
24,800
-4,810
-16% -$498K 0.01% 974
2026
Q1
$2.86M Sell
29,610
-687
-2% -$70.5K 0.01% 841
2025
Q4
$3.22M Sell
30,297
-1,650
-5% -$191K 0.01% 778
2025
Q3
$4.06M Sell
31,947
-258
-0.8% -$30.7K 0.02% 641
2025
Q2
$3.95M Buy
32,205
+2,306
+8% +$263K 0.02% 630
2025
Q1
$3.03M Buy
29,899
+4,374
+17% +$427K 0.01% 759
2024
Q4
$2.36M Buy
25,525
+4,503
+21% +$442K 0.01% 886
2024
Q3
$2.03M Buy
21,022
+7,412
+54% +$666K 0.01% 955
2024
Q2
$1.17M Buy
13,610
+1,139
+9% +$95.6K 0.01% 1234
2024
Q1
$1.03M Buy
12,471
+6,009
+93% +$440K ﹤0.01% 1263
2023
Q4
$432K Buy
+6,462
New +$419K ﹤0.01% 1599

Other funds holding EHC

Pathstone Holdings's EHC Position: Q2 2026 in Review

Pathstone Holdings reduced its Encompass Health (EHC) stake by 16% in Q2 2026, selling an estimated $498K and leaving 24,800 shares worth $2.58M. The position accounts for 0.01% of the portfolio, ranked #974.

Pathstone Holdings first reported a position in EHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.06M in Q3 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Pathstone Holdings held 24,800 shares of Encompass Health worth $2.58M as of Q2 2026.
  • Pathstone Holdings sold 4,810 Encompass Health shares in Q2 2026, an estimated $498K.
  • Encompass Health made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #974 holding.
  • Pathstone Holdings first reported a position in Encompass Health in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Encompass Health position peaked at $4.06M in Q3 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.